Nathaniel Brooks Horwitz

Nathaniel Brooks Horwitz has held various roles in the biotechnology industry since 2019. Nathaniel began their career at RA Capital Management, L.P. as a Venture Partner, then a Principal, a Venture Associate, and finally a Corporate Development Manager. In 2020, they became a Co-Founder & Board Observer of TRIANA Biomedicines, a Board Observer of Synthego Corporation, a Board Observer of Ambagon Therapeutics, and a Co-Founder & Board Director of GentiBio. In 2021, they became a Board Observer of Ventus Therapeutics and a Board Director of New Equilibrium Biosciences. In 2022, they became the Founder & Executive Chair of Mayday.Health, a national 501(c)(3) health education nonprofit, and a Board Observer of Incyclix Bio. Nathaniel also served as a Co-Founder & Board Observer of Avilar Therapeutics in 2019.

Nathaniel Brooks Horwitz graduated from Harvard University with an A.B. in Molecular & Cellular Biology.